Fundamental dimension Equity attribute | ANLPeer $10.580.00% Cap $561.6MP/E -5.4x QuantScore54/100 | APLMPeer $21.84▼-2.17% Cap $63.66MP/E -2.9x QuantScore60/100 | CGENLeader $1.94▼-1.02% Cap $183.8MP/E 5.2x QuantScore67/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
35/100 |
78/100 |
33/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 0/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 63/100 | 22/100 | 63/100 |
Growth Revenue / earnings growth & margins | 90/100 | 100/100 | 80/100 |
Sentiment Analyst ratings, targets & revisions | 83/100 | 100/100 | 83/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -5.4x | -2.9x | 5.2x |
Forward P/E (next FY) | -57.4x | -0.2x | -6.9x |
EV / EBITDA (TTM) | -21.7x | -6.5x | 5.0x |
Price / Sales | 28.5x | 7.5x | 2.5x |
Price / Free Cash Flow | -9.6x | -3.5x | — |
PEG ratio | -0.08 | -0.02 | 0.06 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 2 / 9 | 5 / 9 |
Altman Z-Score | 8.22 (Safe) | -148.00 (Distress) | -0.24 (Distress) |
Total debt / equity | 0.12 | -0.20 | 0.03 |
Quick ratio | 9.5x | 1.0x | 5.7x |
Interest coverage | -17.0x | -145.7x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | +4192.9% | +161.1% |
Net income growth YoY | +31.5% | +79.7% | +348.4% |
Gross margin (TTM) | 100.0% | 100.0% | 86.9% |
Operating margin (FY) | -714.0% | -111.4% | 43.1% |
FCF margin (FY) | -674.5% | -122.0% | 43.1% |
5. Trailing price performancePrice change over period |
1M return | -33.2% | -7.0% | -18.1% |
3M return | -15.4% | +19.9% | -14.9% |
6M return | -28.5% | +64.5% | -37.4% |
Year to date | +645.1% | +16.8% | +26.8% |
1Y return | +541.2% | -5.0% | +7.8% |
3Y return | +24.2% | -76.8% | +160.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.451 -95.7% premium | $-395.03 -1908.7% premium | $-10.14 -622.7% premium |
Wall Street consensus target | $37.33 +252.8% · range $31.00–$49.00 | — — | $5.00 +157.7% · range $5.00–$5.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 100% Buy0% Hold0% Sell | 93% Buy0% Hold7% Sell |